Inventor · disambiguated record
Yan Liu
Also filed as: LIU YAN · LIU YAN-HUI
13 granted patents·14 pending applications·86 citations·filing 2001–2024
89Inventor score
Top patents by PatentIndex Score
27 records- 0196US7807160B2Engineered anti-IL-23 antibodiesSCHERING CORP·Filed 2006·Granted Oct 5, 2010·65 cites·4 claims
- 0287US9044433B2Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndromeUNIV VANDERBILT·Filed 2012·Granted Jun 2, 2015·11 cites·30 claims
- 0380US8513389B2Engineered anti-IL-23p19 antibodiesPRESTA LEONARD G·Filed 2012·Granted Aug 20, 2013·4 cites·7 claims
- 0479US10272133B2Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndromeUNIV VANDERBILT·Filed 2017·Granted Apr 30, 2019·1 cites·5 claims
- 0578US9370549B2Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndromeUNIV VANDERBILT·Filed 2015·Granted Jun 21, 2016·2 cites·18 claims
- 0673US9808501B2Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndromeUNIV VANDERBILT·Filed 2016·Granted Nov 7, 2017·1 cites·27 claims
- 0773US8940506B2High-sensitive fluorescent energy transfer assay using fluoresent amino acids and fluorescent proteinsLIAO JIAYU·Filed 2009·Granted Jan 27, 2015·1 cites·11 claims
- 0871US7442696B2Mineralocorticoid receptor modulator compounds, processes for their preparation, and their usesLIGAND PHARM INC·Filed 2007·Granted Oct 28, 2008·1 cites·60 claims
- 0969US11951150B2Compositions and methods for preventing and reducing inflammation and treating disorders associated with inflammationUNIV VANDERBILT·Filed 2021·Granted Apr 9, 2024·0 cites·6 claims
- 1067US11026992B2Compositions and methods for preventing and reducing inflammation and treating disorders associated with inflammationUNIV VANDERBILT·Filed 2019·Granted Jun 8, 2021·0 cites·13 claims
- 1166US2025161404A1Methods and compositions for the control of inflammation in skin diseaseUNIV VANDERBILT·Filed 2024·Application pending·0 cites
- 1265US2025127772A1Specific tetradentate copper chelators for the treatment of wilson's diseaseUNIV GUANGDONG TECHNOLOGY·Filed 2024·Application pending·0 cites
- 1364US2024238229A1Treatment of pulmonary arterial hypertensionUNITED THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
- 1464US2024293503A1Methods and compositions for treating microbial inflammationUNIV VANDERBILT·Filed 2023·Application pending·0 cites
- 1559US10342847B2Compositions and methods for preventing and reducing inflammation and treating disorders associated with inflammationUNIV VANDERBILT·Filed 2016·Granted Jul 9, 2019·0 cites·12 claims
- 1658US9809648B2Engineered anti-IL-23p19 antibodiesMERCK SHARP & DOHME·Filed 2012·Granted Nov 7, 2017·0 cites·12 claims
- 1757US2024075124A1Stable formulation of human papillomavirus virus-like particle vaccineSINOCELLTECH LTD·Filed 2022·Application pending·0 cites
- 1856US2010111966A1Engineered anti-il-23p19 antibodiesSCHERING CORP·Filed 2008·Application pending·0 cites
- 1954US2017370916A1High-sensitive fluorescent energy transfer assay using fluorescent amino acids and fluorescent proteinsUNIV CALIFORNIA·Filed 2017·Application pending·0 cites
- 2052US11771739B2Methods and compositions for treating microbial inflammationUNIV VANDERBILT·Filed 2018·Granted Oct 3, 2023·0 cites·6 claims
- 2151US2015369800A1High-sensitive fluorescent energy transfer assay using fluorescent amino acids and fluoresent proteinsUNIV CALIFORNIA·Filed 2015·Application pending·0 cites
- 2251US2023272106A1Stable formulation for recombinant anti-pd-1 monoclonal antibodySINOCELLTECH LTD·Filed 2021·Application pending·0 cites
- 2349US2011002942A1Engineered Anti-IL-23 AntibodiesSCHERING CORP·Filed 2010·Application pending·0 cites
- 2446US2022072095A1Methods and compositions for treating skin diseasesUNIV VANDERBILT·Filed 2019·Application pending·0 cites
- 2544US2007254917A1Intracellular receptor modulator compounds and methodsHIGUCHI ROBERT I·Filed 2007·Application pending·0 cites
- 2643US2019298901A1Heterochronic blood exchange as a modality to influence myogenesis, neurogenesis, and liver regenerationUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 2740US2001046497A1G-protein coupled receptor and methodsFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →